Portfolio Strategy and Business Development

Disease Landscape and Forecast

Optimize the value of your assets with comprehensive, indication-specific market insights.

Enhance your disease strategy with comprehensive market landscape data and analysis.

Identify high-potential markets and strategically position your product for success with in-depth disease landscape insights.

Assess and Prioritize Opportunities

Evaluate market potential for your assets—and those of your competitors—to refine your strategy with indication-specific intelligence and world-class epidemiology.

Identify Unmet Needs

Analyze gaps in care and align your clinical development strategy with the areas offering the greatest opportunity.

Drive Successful Market Access

Strengthen your market access strategy with brand-level insights into how payer policies influence physician prescribing behavior.

Gain Rapid Insights into the Disease Market Landscape

Extensive Therapy Area Coverage

Explore detailed market outlooks for 85+ indications, including rare and niche diseases, plus executive insights for 45+ additional conditions.

Comprehensive and In-Depth Insights

Access syndicated intelligence on market dynamics, challenges, drivers, and unmet needs, paired with 10-year sales forecasts.

Unmatched Domain Expertise

Leverage insights from industry-leading specialists—including analysts, therapy area experts, epidemiologists, data scientists, physicians, and pharmacists—who possess deep global market and therapeutic knowledge.

Comprehensive market intelligence to optimize your disease strategy

Forecast with confidence

Using a bottom-up forecasting methodology based on top-line epidemiology data, our 10-year, annualized market forecasts feature drug-level sales and patient shares of key therapies segmented by brands/generics.

Dive deeper into disease management insights

Featuring primary market research and RWD – including patient-level claims data – our in-depth insights into critical areas of treatment analysis, unmet need, and access & reimbursement span 130+ diseases and topics.

Optimize your strategy in China

Geographically diverse insights to help your business succeed in this lucrative market, featuring world-class epidemiology, insight into the complex access and reimbursement environment, current treatment paradigms data, and 10-year, annualized, drug-level forecasts.